Tag: respiratory disease
Australia invests in local manufacturing of AI tools for respiratory disease
Australian health technology company Diag-Nose.io has secured $3 million in federal funding to advance local manufacturing and clinical validation of an artificial intelligence-powered diagnostic platform designed to improve treatment of respiratory disease.
Featured Article
Australian Manufacturing Week 2026 enters final run-up to Brisbane debut
Australia’s manufacturing sector continues to play a critical role in the national economy, underpinned by ongoing investment in advanced technologies, automation, and high-value production.
